Similar Search Results

Ask your doctor or pharmacist! : on the effect of self-dispensing physicians on pharmaceutical coverage

Bannert, Matthias; Iselin, David - 2015

In most developed countries drugs are dispensed to patients through physicians and pharmacists. This paper studies the effects of allowing doctors to directly dispense drugs to patients (self-dispensation) on pharmaceutical coverage. We use a Swiss dataset in our empirical analysis because...

Persistent link: https://www.econbiz.de/10011280788

Cost-Containment Policies in Public Pharmaceutical Spending in the EU

Carone, Giuseppe - 2012

This paper presents and evaluates pharmaceutical policies in the EU aimed at the rational use of medicines and at keeping pharmaceutical spending under control. Policy makers are growing more aware that by regulating pharmaceutical markets correctly, considerable savings can be achieved without...

Persistent link: https://www.econbiz.de/10013099332

Pharmaceutical Cost-Sharing Systems and Savings for Health Care Systems from Parallel Trade

Birg, Laura - 2013

This paper analyzes the consequences of parallel trade on health care systems in a two-country model with a vertical distributor relationship. In particular, two cost-sharing systems coinsurance and indemnity insurance are compared with respect to changes in copayments and public health...

Persistent link: https://www.econbiz.de/10013071665

Prescription Drug Insurance Plans : Potential Cost Reductions and the Pass-Through of Manufacturer Pharmaceutical Rebates to Premiums

Yang, Charles C. - 2019

In response to the recent moves to reduce prescription drug expenses and eliminate manufacturer pharmaceutical rebates for Medicare and Medicaid, this research investigates the pass-through of manufacturer pharmaceutical rebates to premiums and examines the potential prescription drug cost...

Persistent link: https://www.econbiz.de/10012859130

The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany

Dintsios, C. M.; Beinhauer, I. - In: Health economics review 10 (2020) 7, pp. 1-25

Background: We analysed the impact of clinical study design for oncological pharmaceuticals on the subsequent price … Health Insurance Funds. The analysis was conducted for all oncology pharmaceuticals that underwent the early benefit …. Further analyses should be performed when more oncology pharmaceuticals have passed the early benefit assessment. …

Persistent link: https://www.econbiz.de/10012291135

Implementing personalized medicine with asymmetric information on prevalence rates

Antoñanzas Villar, Fernando; Juárez-Castelló, Carmelo A. - In: Health economics review 6 (2016) 35, pp. 1-8

Although personalized medicine is becoming the new paradigm to manage some diseases, the economics of personalized medicine have only focused on assessing the efficiency of specific treatments, lacking a theoretical framework analyzing the interactions between pharmaceutical firms and healthcare...

Persistent link: https://www.econbiz.de/10011586604

Extra costs of integrity : pharmacy markups and generic substitution in Finland

Izhak, Olena - 2019

I evaluate how the probability of substitution of a prescribed drug in a pharmacy depends on the pharmacists' profits and patients' out of pocket costs. I use Finnish population-wide data covering all prescriptions of three popular antidepressants. I find that one euro increase in the total...

Persistent link: https://www.econbiz.de/10011954334

A prescription for knowledge : patient information and generic substitution

Hjalmarsson, Linn; Schmid, Christian; Schreiner, Nicolas - 2024

Markets require informed participants to function efficiently. This paper examines the impact of providing targeted information directly to patients on their purchasing-decisions regarding pharmaceutical drugs. We analyze the effect of informational letters sent by a Swiss health insurer to...

Persistent link: https://www.econbiz.de/10014545146

The effect of higher out-of-pocket payments on drug prices and demand

Loetscher, Fabienne; Schmid, Christian; Gerfin, Michael - 2024

, Switzerland introduced out-of-pocket price differentiation. As of July 1st 2011, substitutable pharmaceuticals with prices above a …

Persistent link: https://www.econbiz.de/10014551351

Is Pharmaceutical Detailing Informative? Evidence from Contraindicated Drug Prescriptions

Huang, Guofang - 2018

Crestor, an important but controversial cholesterol-lowering drug, is contraindicated for use by senior and Asian patients. In this paper, we exploit this fact and a unique doctor-level prescription and advertising (detailing, to be exact) exposure data for statin drugs to examine the hypothesis...

Persistent link: https://www.econbiz.de/10012940309

1
2
3
4
5
6
7
8
9
10
Next
Last